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Abstract:  
 
The aim of this paper is to present the 
composition and functioning of the EU institutions 
involved in receiving, analysing, approval or 
rejection of the application for the use of genetically 
modified organisms. The manner of participation of 
each institution is presented by using the 
comparative and historical method, as well as the 
method of analysis. The advantage of these methods 
is a detailed analysis of the rights and 
responsibilities of all participants in the approval 
process for genetically modified organisms.  
 
 
 
The paper analyses all the EU institutions that are 
directly or indirectly associated with the approval 
procedure, and those are: European Food Safety 
Authority, European Parliament, European 
Commission and Court of Justice of the European 
Union. The problem of the whole institutional 
framework is an insufficient contribution of the 
constituent activity of the EU member states and 
their national authorities and whole process should 
be based more on the principle of subsidiarity. 
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Introduction     
Genetically modified organisms (GMOs) are still 
unknown term in the world. Or they are simply 
unknown to some final consumers so as not to cause 
further panic among the population. Every now and 
then we have a chance to read about the genetically 
modified organisms and their consequences. The 
predecessors of genetically modified organisms, in 
the harsh sense of the word, are cloning and 
eugenics because the basic meaning of both is an 
artificial effect on life. So, we can say that a man is 
dealing with this issue for many years. With all the 
numerous approaches to genetically modified 
organisms, the focus of this paper is on EU 
institutions that are involved in the approval 
procedure. As an independent institution that 
participates in the approval procedure is the 
European Food Safety Authority (EFSA). The EFSA is 
crucial for risk assessment of food and feed and its 
safety. As an independent body, the EFSA provides 
scientific advices and it is a centre of information 
exchange. The European Parliament participates in 
the legislative procedure and through that 
legislative procedure it affects the position of GMOs. 
The European Commission has an important role 
because it is consisted from various institutes and 
research centres specialized in studies on food and 
the impact of GMOs on food. The last institution 
regarding the GMOs regulation is the Court of Justice 
of the European Union. The Court of Justice of the 
European Union with its concrete, life action creates 
the case-low, and thus forms the status of 
genetically modified organisms.  
European Food Safety Authority 
The purposefulness of activity of agencies is in fact 
of creation of a special body whose function is to 
perform regulatory and other tasks from the relevant 
areas. Regulatory agencies came from the US 
regulatory independent commissions and agencies. 
The characteristics of them are: activities are 
performed independently of political influence; 
employees of the same agencies reflect 
professionalism, quality, reliability; this way of 
functioning ensures more detailed regulation and 
knowledge of the individual parts of the system; 
provides better control and better legal protection of 
users and consumers. In the field of genetically 
modified organisms the European Agency Food 
Safety Authority appears. 
"The European Food Safety Authority (EFSA) is key 
agency in the European Union (hereinafter referred 
to as: EU) for risk assessment of food and feed. In 
close collaboration with national authorities and in 
open consultation with its stakeholders, EFSA offers 
independent scientific advice and clear 
communication on existing and future risks. "[1] 
The purpose was to form an independent body that 
would be a source of scientific advice and 
communication on risks when it comes to food for 
both human and for animal consumption. As for 
legal status, EFSA has legal personality and acts 
independently of the institutions of the European 
Union. The founders are the European Parliament 
and Council via Regulation 178/2002. 
 One reason for creation of this agency is a series of 
food scandals which have occurred during the 1990s. 
It is necessary to protect consumers, improve food 
safety and to retain existing and restore lost 
confidence in the food supply in the EU. Since the risk 
assessment is carried out separately from risk 
management, the EFSA, with its scientific opinions 
and advice, constitutes the basis of European 
policies and legislation and support to the European 
Commission, European Parliament and Member 
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States in order to make appropriate decisions in risk 
management. Areas of action EFSA are: food and 
animal feed safety, nutrition, animal health and 
welfare and plant protection.  
 The role of EFSA is to point out all the risks in the food 
chain. The basis for EFSA action is self-initiative, but 
it also acts at the request of the European 
Commission, European Parliament and Member 
States. It is not included in the decision making or 
management, for example in the process of adoption 
or revision of EU legislation on food and animal feed 
safety, the process of approval of certain additives, 
pesticides etc., "but aims to provide appropriate, 
consistent, correct and timely information on food 
safety to all interested parties and the public at 
large on the basis of their own risk assessment and 
scientific expertise". [1] The EFSA has so far issued 
over 450 scientific opinions on, for example, bovine 
spongiform encephalopathy (BSE), transmissible 
spongiform encephalopathy (TSE), safety of many 
food additives (GMO, wild and farmed fish, etc.). In 
addition, EFSA works and on its own initiative, so-
called self-tasking, especially in the areas where the 
risks are still emerging, and where scientific 
approaches and knowledge are still at the starting 
levels. In order to ensure complete "scientific 
integrity and to stay informed", EFSA is working with 
other Member States in order to collect the 
appropriate scientific data. 
 Article 22 of Regulation 178/2002 states the mission 
of EFSA, which, in that sense, is: to provide scientific 
advice and scientific and technical support in all 
situations that have points of contact with food or 
feed; taking care of the system of protection of 
people and their health, animal health and welfare, 
plant health and the environment; collect the 
necessary data to be able to properly monitor the 
risks associated with food and feed etc.  
The task of the EFSA is to: 
"Provide the Community institutions and Member 
States with the best possible scientific opinions in 
all areas provided for by Community legislation or 
any other question within the mission; 
enhance and coordinate the development of uniform 
risk assessment methodologies in all areas within 
its mission; 
provide scientific and technical support to the 
Commission in all areas of the mission and, when 
prompted, interpretation and consideration of risk 
assessment opinions; 
carry out their scientific studies necessary for the 
achievement of the mission; 
search for, collect, collate, analyse and summarize 
scientific and technical data in the fields within its 
mission; 
take action to identify and characterize emerging 
risks in the fields within its mission; 
establish a system of networks of organizations 
operating in all areas of the mission and be 
responsible for their work;…" [2] 
  
Regulation 178/2002 lists the individual principles 
that mark EFSA actions and effects: 
1. the first principle that is mentioned is the 
principle of independence, according to which 
the members of the Board, the Advisory Forum 
and the Director shall act in the public interest. 
They are required annually to, in writing, sign a 
declaration of commitment and a declaration 
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of the absence of any direct or indirect 
interests that could affect their independence. 
2. Transparency of the EFSA is ensured by the 
following actions: publication of agendas and 
minutes of the Scientific Committee and 
Scientific Council and opinions of the same 
immediately after acceptance; the publication 
of information that make up the opinion; 
publication of the annual interests statements 
of members of the Board of Directors, Advisory 
Forum, Scientific Committee and Scientific 
Council and the Director General; publishing 
the results of their scientific research; the 
publication of annual reports on their 
activities; publishing requests from the 
European Parliament, the Commission or 
Member States when scientific opinion is 
rejected or changed and stating the reasons for 
rejection or changes. 
3. regarding confidentiality, all the information 
needed in order to ensure public health shall be 
published while other information is 
confidential and shall not be disclosed to third 
parties. 
4. the principle of communication by which EFSA 
communicates in a way that all interested 
parties receive reliable, objective and 
accessible information. 
5. access to documents has to be greatly 
emphasized. 
6. EFSA maintains contacts with representatives 
of consumers, producers and other interested 
parties. 
 EFSA is composed of the following bodies: Board of 
Directors, Director with his staff, the Advisory Forum 
and Scientific Committee and Scientific Council. The 
board consists of 14 members appointed by the 
Council in cooperation with the European Parliament 
and on the basis of a list drawn up by the European 
Commission, with one member being a 
representative of the European Commission. They 
serve for four years and their mandate can be 
reappointment once. They meet on the proposal of 
the President or at least a third of its members. The 
meetings are attended the Board and Director, but 
without voting rights. Board shall appoint the 
Director General for a term of five years with the 
possibility of reappointment. The list of candidates 
published by the European Commission after a 
public competition in the Official Journal of the 
European Union and elsewhere, depending on the 
needs. Before appointment, the candidate 
nominated by the Board will be invited to the 
European Parliament to give a statement and 
answered questions. The Director may be removed by 
the Board of Directors by majority of its members.  
 Next body, according to Regulation 178/2002, the 
Advisory Forum consists of representatives of 
Member States, or their competent authorities which 
perform similar tasks as the EFSA. Each Member 
State sends one representative.But that 
representative cannot be a member of the Board of 
Directors. Advisory Forum has the following powers: 
advises the Director General regarding his/her 
obligations under Regulation 178/2002, and in 
particular on the draft of EFSA work program and the 
priority of the applications submitted for scientific 
advice; 
is a mechanism of exchange of information on 
potential risks and ensure close cooperation 
between EFSA and the competent authorities of 
Member States. 
 The last bodies in the line are the Scientific 
Committee and scientific councils, which are 
responsible for providing scientific opinions 
according to their competences and have the ability 
to, when needed, organize public hearings. The 
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Scientific Committee is responsible for ensuring 
overall coordination when it comes to consistency of 
scientific opinions procedures. It consists of the 
president of the scientific council and six 
independent experts who may not be members of the 
scientific councils.  
 The Council for genetically modified organisms 
(hereinafter referred to as: the Council) studies 
GMOs and GM food and GM feed. Members of the 
Council are appointed by the EFSA and the Board of 
Directors for three years with the possibility of 
reappointment. Appointments are made on the basis 
of open competition and after strict assessment of 
candidates. Council members sign the declaration 
of interests to ensure their independence during 
operation. In terms of procedure, the Council is of 
great importance because the Commission shall 
forward the request and ask EFSA for a scientific risk 
assessment. The Board performs a detailed risk 
assessment on the safety. Detailed analysis 
consists of 21 independent experts in the Council for 
the following areas: biochemistry, microbiology of 
food and organic food, soil microbiology, molecular 
biology, genetics, toxicology, pathology animal, 
immunology, biotechnology, food science, ecology, 
biology of plants, agronomy, entomology and 
statistics. 
 There is a situation wen different scientific opinions 
arise and where there is a disagreement between the 
EFSA's scientific opinions and the scientific opinions 
of other bodies performing similar tasks, and in 
such situations a cooperation between them is 
organized. 
In order to ensure faster and easier communication, 
exchange of information, theoretical and practical 
knowledge EFSA promotes European networking of 
organizations participating in the areas of EFSA's 
mission. List of competent authorities of the 
Member States which take part in EFSA's mission is 
drafted by the Administrative Committee on a 
proposal from the Director General. EFSA Networks 
consists of a number of organizations and experts 
from Member States, led by EFSA and supported by its 
appropriate units.  
 European Parliament 
 The European Parliament is a representative of the 
citizens, and is elected every five years in a direct 
way. Its main functions are: adopts European laws 
together with the Council of Ministers; cooperates 
with other institutions in order to check the 
democratic nature of action; together with the 
Council of Ministers discusses the budget and 
adopts the same. After the Lisbon Treaty, the 
position of the European Parliament is greatly 
changed. Namely, it cooperates with the Council of 
Ministers in the ordinary legislative procedure, i.e. 
co-decision procedure in the field of consumer 
protection, the environment, etc., but after the 
Lisbon Treaty Parliament's influence spread to some 
other areas, such as agriculture, energy policy, 
immigration and EU funds. The seat of the European 
Parliament is in three cities: Brussels, Strasbourg 
and Luxembourg, with administrative offices based 
in Luxembourg, plenary sessions are held in 
Strasbourg and Brussels, meetings of the Committee 
are held only in Brussels.  
The legislative process is also significantly amended 
by the Lisbon Treaty. The legislative procedure or co-
decision procedure was introduced by the 
Maastricht Treaty in 1992 and amended by the Treaty 
of Amsterdam. The entry into force of the Lisbon 
Treaty the same is called ordinary legislative 
procedure, but also has become the main legislative 
procedure in the European legal system. The ordinary 
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legislative procedure in a number of policy equates 
legal power of the European Parliament and the 
Council of Ministers, i.e. a number of laws are 
adopted together by the European Parliament and 
the Council. 
 European Commission 
 The European Commission represents the interests 
of the EU and constitutes one of the fundamental 
institutions. Its main task is to implement policies 
and channel the funds from the European funds. 
Within the Commission acts Directorate General for 
Health and Food Safety (hereinafter referred to as DG 
SANTE) whose main goal is "to make Europe a 
healthier, safer place where consumers can be 
assured that their interests are protected. „The fact 
is that it is impossible to establish a zero risk to 
consumers or society as a whole, but in any case, DG 
SANTE operates in terms of risk reduction and 
management. The objectives of DG SANTE are:  
1. "to protect and improve public health 
2. ensure that European food is safe and healthy, 
3. protect the health and welfare of farm animals, 
4. protect the health of crops and forests." [3] 
In terms of methodology, DG SANTE has planned the 
following activities: monitoring (monitoring 
regulations, and their implementation at national, 
regional or local level that are related to food safety, 
consumer rights and public health); listening (this 
implies involvement of all stakeholders in the 
process); action (action depending on the particular 
circumstances, and taking into account a number of 
laws, regulations, projects, etc.).  
 Joint Research Centre,( hereinafter referred to as 
JRC) is a Directorate General of the European 
Commission. It is based in Brussels, and its function 
is to provide a number of scientific and technical 
information in areas of EU policy. It was founded by 
the Founding Treaty of 1957, or the Euratom Treaty. 
Since the role of Euratom agreements promoting 
nuclear safety and security in general in Europe, the 
JRC's own scientific and technical support is 
focused in this direction. However, over time the JRC 
has expanded its areas of activity in other domains 
including life sciences, energy, security and 
consumer protection. Institute for Health and 
Consumer Protection (hereinafter referred to as: 
IHCP) is one of the seven institutes of the JRC and is 
responsible for protecting the interests and health 
of consumers by providing scientific and technical 
assistance to assessing the risks and benefits and 
by controlling traceability. The activities are focused 
in the following areas: GMOs, nanotechnology, 
health and the environment, consumer products and 
nutrition, alternatives in situations involving animal 
testing. The JRC has for years worked on the creation 
and adaptation of funds and tools used for tracking 
GMOs that are put on the market, and also to prevent 
the "entry" of unapproved GMOS. IHCP plans to, one 
the basis of Reference Laboratory for GM Food and 
Feed (hereinafter referred to as: EURL-GMFF) 
introduce a uniform method that would be applied in 
all laboratories and would allow detection and 
determination of quantities of GMOs in food and 
feed. Today’s role and importance of EURL-GMFF was 
established in 2004 by defining the status of the 
European GMO legislation. Its duties and 
responsibilities are as follows: assessment of the 
validity of methods of detection of GM food and feed 
and scientific risk assessment; preparation and 
distribution of the control samples to the competent 
laboratories; competence in solving potential 
disputes between the laboratories of the Member 
States when it comes to different results in 
detecting GMOs; to help the national reference 
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laboratories. All data on all phases of the discovery, 
validation, etc., are available on the Internet 
(description of the event, a unique identifier of 
GMOs, information about the applicant, check the 
status of the validity of the required methods). The 
same information is reported to the EFSA and 
published on its website. In addition, it acts as a 
coordinator when it comes to national reference 
laboratories and their detection methods. It is 
important to emphasize that, for the purpose of 
standardization out cooperation with the European 
Network of GMO Laboratories (hereinafter referred to 
as: ENGL) is carried out. ENGL is a collection of 
European experts who play a significant role in the 
development and harmonization of testing methods, 
detection, identification and quantification of GMOs. 
It was opened on 4th of December 2002 in Brussels 
and currently consists of more than 100 national 
reference laboratories of all Member States and also 
from Norway and Switzerland. 
 When it comes to other areas, or the area of health 
and the environment, IHPC examines the risks 
associated with: air pollution, chemicals, 
pesticides, noise, etc. In order to provide high quality 
in this area, IHPC collaborates with other 
departments of the European Commission, other 
organizations in the European Union, the World 
Health Organization and other parties. In the area of 
consumer goods and food, IHPC assess the benefits 
and risks of food products with respect to human 
health. 
 The practice of the Court of justice of the European 
Union on genetically modified organisms 
 After principles, legal rules and organizational 
forms it is necessary to mention the "last cog in a 
wheel”, i.e. courts that participate in application of 
laws. Courts "give life" to a rigid legal rule and 
separate judgments of the Court of Justice of the 
European Union are stated on the issues of GMOs.  
 The Court of Justice (there is a controversy 
regarding the translation and the use of the term 
"justice" in the terminology of the Court. For 
example, the term is used in English, French, Italian 
system while the Germans omitted that term of the 
official name) of the European Union has three 
judicial authorities: the European Court of Justice), 
the General Court and specialised courts. The Lisbon 
Treaty also changed the name of the Court of First 
Instance into the General Court. The seat of the Court 
is in Luxembourg. Within the European Court 
operates one judge from each member state and 11 
independent lawyers. The General Court is also made 
up of one judge from each Member State, and the 
composition of the specialized court is defined by 
the founding act, i.e. a decree. The choice of judges 
and prosecutors is done at the national level, and 
they are elected by the governments of the Member 
States via mutual agreement. However, the novelty 
brought by the Lisbon Treaty is the establishment of 
the Committee (Article 255 of the TFEU), whose 
function is to give opinions on the suitability of the 
candidate. Change came with the Charter of 
Fundamental Rights of the EU. The status of the 
Charter is legally binding, so a question arose 
regarding the emergence and regulation of 
individual rights, for example "ban on the creation 
of human body or parts that would be a source of 
financial gain"[4] , "ban on cloning of human 
beings“ [4]. The application of the Charter is limited 
and difficult because the same does not apply to 
regulations of Poland and Great Britain. 
 The Lisbon Treaty introduced significant changes in 
some procedures. So, the novelty refers to the 
system of direct judicial review or submission of a 
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claim for annulment of: legally binding acts of the 
European Council, offices and agencies (so far the 
ability to control depended on the legal nature of the 
legal act) and other bodies. Active legitimation is 
also expanded in terms of the individual as the 
applicant (Article 230 of the EU Treaty, and in terms of 
procedural legitimacy of individuals, stated: "Any 
natural or legal person may, under the same 
conditions, institute proceedings against a decision 
addressed to that person or against a decision 
which, although in the form of a regulation or 
decision addressed to another person, is of direct 
and individual effect on the last." However, in Article 
263/4 of the Treaty on the Functioning of the 
European Union applicant's status is changed to 
read as follows: "Every natural or legal person may, 
under the conditions set out in the first and second 
paragraphs, institute proceedings against 
addressed to that decision or that the same person 
of direct and individual concern, and against a 
regulatory act which is of direct interest to them, 
and not require any implementing measures." There 
are differences in those interpretation (for example 
the deletion of certain expressions, defining the 
regulatory act, implementing measures etc.) and the 
meaning depends on the Court's interpretation of 
the Court of the EU, and the Committee of the Regions 
(based on Article 263/3 of the Treaty on the 
Functioning of the European Union: "The Court has 
jurisdiction under the same conditions in actions 
brought by the Court of Auditors, the European 
Central Bank and the Committee of the Regions for 
the purpose of protecting their prerogatives." In 
addition, Article 8 (2) of the Protocol on the 
application of the principles of subsidiarity and 
proportionality clearly emphasizes the following: 
"... The Committee of the Regions can take such 
actions against legislative acts for the adoption of 
which the Treaty on the Functioning of the European 
Union provided for consultation", and indirectly to 
the national parliaments (apart from changes 
envisaged in the Lisbon Treaty, the Protocol no. 2 on 
the application of the principles of subsidiarity and 
proportionality in Article 8 (1), which stipulates: "The 
Court of Justice of the European Union shall have 
jurisdiction in cases of violation of the principle of 
subsidiarity, the legislative acts adopted in 
accordance with Article 263 of the Treaty on the 
Functioning of the European Union by Member 
States, or is notified in accordance with their legal 
order by the national parliaments or their houses.” 
 In addition to these changes, the Court has given the 
power to control the validity and interpretation of 
acts of agencies, bodies and offices. The novelty of 
the system is the introduction of an emergency 
preliminary ruling procedure when prompted by the 
national court before which the action is being taken 
for a person who is in custody. Emergency 
preliminary proceedings were initiated on 1st of 
March 2008, relating to the third pillar of the EU and 
Title IV, Part Three of the EC Treaty, that is 
thematically focused on the areas of visa, asylum, 
immigration and other policies related to free 
movement of persons (from Article 61 to 69). Thus, the 
effect of the Court, in regard to the previous 
procedure, is focused on preliminary issues related 
to the area of freedom, security and justice, and 
situations in which a persons before the national 
courts of the Member States is in custody. 
Several rulings by the Court that are highlighted 
which are, in fact, indicators of the practical 
application of legal rules. If you start from the newer 
verdicts, the first in the series refers to the judgment 
of the Court (Grand Chamber) of 6th of September 
2011 (Case C-442/09 Karl Heinz Bablok and Others vs. 
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Freistaat Bayern [2011] ECR Page 00000) which refers 
to Regulation (EC) No. 1829/2003 (Articles 2 to 4 and 
Article 12), Directive 2001/18 / EC (Article 2), Directive 
2000/13 / EC (Article 6) of Regulation (EC) No. 178/2002 
(Article 2). The judgment refers to the presence of 
pollen from GM plants and side effects when put on 
the market, the definition of “organism” and “food 
for human consumption containing ingredients 
produced from genetically modified organisms." 
According to Article 2.5 of Regulation (EC) No. 
1829/2003 the definition of GMOs does not include 
pollen derived from a variety of GM maize, which has 
lost the ability to reproduce and is totally incapable 
of transferring the genetic material which it 
contains. In accordance with Articles 2.1, 2.10 and 
2.13 and Article 3 (1) (c) of Regulation 1829/2003, 
Article 2. Regulation 178/2002, Article 6 (4) (a) of 
Directive 2000/13 / EC the following matter is not 
considered to be GMO: pollen containing genetically 
modified DNA or genetically modified protein; 
products such as honey or food supplement 
containing such substances that represent "food ... 
containing ingredients produced from [genetically 
modified organisms]”. Furthermore, Articles 3 (1) 
and 4 (2) of Regulation 1829/2003 imply an obligation 
of authorization and supervision of food and the 
tolerance on the labelling, provided for in Article 12 
(2) of the same Regulation cannot be applied 
analogously to the previous articles. 
 The following case T-139/07 (Case T-139/07 Pioneer Hi-
Bred International vs. Commission) refers to appear 
before Court of First Instance between the "Pioneer 
Hi-Bred International” against the Commission on 
4th of September 2009 on the approximation of laws 
during the deliberate release of genetically modified 
organisms into the environment. The applicant was 
“Pioneer Hi-Bred International”, and respondent 
was the Commission of the European Communities. 
The aim of this action was towards the 
harmonization of rules on release of genetically 
modified maize 1507 to the market, but the 
Commission has failed to fulfil its obligations 
provided for in Article 18 (1) of Directive 2001/18 / EC. 
Since there has been a failure, there is no need for 
court ruling and the Commission shall reimburse its 
costs and expenses of the applicant. 
 Ruling of the Court of First Instance (Fourth 
Chamber) of 5th of October 2005 is a dispute between 
Land Oberösterreich and the Republic of Austria and 
the Commission of the European Communities on the 
harmonization of legislation and national provisions 
on the derogation from harmonization measures, 
ban on use of genetically modified organisms in 
Upper Austria and the conditions for the application 
of Article 95 (5) of the EC Treaty (Joined cases T-366/03 
and T-235/04 Land Oberösterreich and Republic of 
Austria vs. Commission of the European 
Communities [2005] ECR II-04005) which reads: "... 
after harmonization measures are adopted by the 
Council or the Commission, and a Member State 
deems it necessary to adopt new national provisions 
based on new scientific evidence relating to the 
protection of the environment or the working 
environment based on problems specific to a 
Member State, provided that the same occurred after 
the adoption of the measures, the duty of a Member 
State is to inform the Commission of the 
implementation thereof and the reasons for the 
implementation". The verdict was in favour of the 
European Commission. On appeal (Joined Cases C-
439/05 P and C-454/05 P) a verdict was issued on 13th 
of September 2007, also not in the favour of the 
Republic of Austria.  
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Conclusion 
The system of genetically modified organisms 
(GMOs) is contradictory to the principle of 
subsidiarity. That principle, in the harsh sense of the 
word, is the basic setting and the starting point in 
relation to European and national. Namely, the 
member states in the current situation can only ask 
questions and look for reasons, as well as they can 
hope that the mentioned system is not just a "pass" 
for multinational companies. The current approval 
system is well designed, but only for the purposes of 
international trade. Only in that scenario, the 
uniform and centralised system can be justified. 
But, there must be awareness that it is difficult to 
establish a uniform system at the global level. That 
is because of different interpretations and 
approaches to a number of terms, problems and 
uncertainties due to the diversity of all member 
states. The evidence of centralization is also the fact 
that the risk assessment and final decision perform 
EFSA and European Commission Standing Committee 
on Plants, Animals, Food and Feed. The self-
organization of the mentioned institutions, their 
activity, and the way of relating to the member states 
should be focused on the principle of subsidiarity. 
The member states have already indicated their 
freedom of decision making and acting, on their 
biodiversity which is different from one to the other. 
They pointed difficulties that arise by adopting a 
centralized system of approval of GM food and feed. 
They also referred on national orientation of that 
matter and editing system in accordance with 
national regulations and needs, with mandatory 
participation of the public, while respecting the 
provisions of environmental and consumer 
protection. Therefore, the organization should focus 
on self-organization and autopiesis theory, with 
reference to natural laws as a starting point. The 
starting point of every action should be the lowest 
level of activity, including the participation of 
citizens. Whereat, each part of the system has its 
whole, its subjectivity, and again represents a 
coherent whole with other systems. The system was 
not created by the method of induction but by the 
method of deduction. The criticism of the system of 
genetic engineering is that, when designing 
regulations, the integral social development is not 
taken into account. The individual "development" 
and a contribution were bypassed because the 
participation of citizens in policy-making of genetic 
engineering did not come to the fore. The centre of 
mission should be the system of action "from 
below", the so called “bottom-up” approach. 
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